Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ready Capital Corporation Reports Fourth Quarter 2024 Results and Declares First Quarter 2025 Dividends
-
Monroe Capital Corporation BDC Announces Fourth Quarter and Full Year 2024 Results
-
Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery
-
Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance
-
Almaden Enters into Agreement to Sell the Rock Creek Mill
-
Occidental Announces Offer to Exercise Warrants at a Temporarily Reduced Price
-
Revival Gold Closes Strategic Placement with Dundee Corporation
-
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025
-
Y-mAbs Announces Publication of Phase 2 Interim Results in Nature Communications
-
American Tungsten Announces Marketing Agreement
-
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance
-
Coppernico Provides Update on Drilling and New Epithermal and Skarn Targets
-
Garuda Therapeutics Announces the Appointment of Avanish Vellanki as President and Chief Executive Officer
-
Miata Metals Announces Arrival of Drill Crew and Samples of up to 39.16 g/t Gold at the Sela Creek Project in Suriname
-
Midland, in Partnership With Rio Tinto Exploration Canada, Resumes Drilling for Lithium on the Galinée Project
-
Canadian North Resources Inc. Expands Metallurgical Programs Applying Low-carbon Footprint Bioleaching Technology on Ferguson Lake Ni-Cu-Co PGE project
-
Altimmune to Participate in the Leerink Global Healthcare Conference
-
Stereotaxis Reports 2024 Full Year Financial Results
-
SL Green Signs 144,000 Square Foot Renewal and Expansion Lease with Newmark at 125 Park Avenue
-
Bombardier’s Record-Breaking Global 7500 Business Jet Achieves Category-Leading 100th Speed Record
-
Cassava Sciences Reports 2024 Financial Results and Provides Business Update
-
Glass House Brands Announces New $50 Million Senior Secured Loan
-
Digihost Provides February 2025 Production Update, Including Record Energy Revenue and 38% Increase in Total Monthly Revenue, and Announces Appointment of New Director
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference
-
Top Health Economics Expert Professor Jonathan Kolstad Affiliates with Compass Lexecon
-
Meriaura Group Oyj: Meriaura Group Plc’s annual report for 2024 published
-
Invesco Ltd: Form 8.3 - American Axle & Manufacturing Holdings Inc; Public dealing disclosure
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 28 02 2025] - (CGWL)
-
Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025
-
Volatus Aerospace and Draganfly Expand Collaboration to Service High-Value Geospatial Power Utility Customers
-
Invitation to HMS Networks’ Capital Markets Day on September 9, 2025
-
ProVen Growth and Income VCT plc: Total voting rights
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
The Joint Corp. to Participate in the 37th Annual Roth Conference
-
ProVen VCT plc: Total voting rights
-
Politecnico di Torino flies to Ethiopia for an institutional mission
-
Abcourt Announces Strategic Partnership With Groupe Minier Technica
-
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results
-
Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
ROME Therapeutics Announces Publication in Nature Communications of First Large-Scale, Pan-Cancer Analysis of LINE-1 Expression Levels and Retrotransposon Activity
-
Emerita Announces Commencement of Hearings to Resolve Corruption Charges Related to Awarding of Aznalcollar Public Tender, Spain
-
Ryman Hospitality Properties, Inc. Provides Investor Presentation Ahead of Upcoming Institutional Investor Conferences
-
Lexicon Pharmaceuticals Announces Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain
-
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
-
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urolo
-
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results
-
ArriVent BioPharma Reports Full Year 2024 Financial Results
-
Opthea Announces Phase 2b Wet AMD Publication
-
ScottsMiracle-Gro to Webcast Presentation at Raymond James & Associates 46th Annual Institutional Investors Conference on March 4
